Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure

Prior treatment

• Cardiac device or cardiac surgery in the previous month or planned in the next 3 months.

Other illness

• Chronic kidney disease with glomerular filtration rate \< 20 mL/min.
• Decompensated thyroid disease.
• End-stage liver failure or Child-Pugh C.
• Patients with dyspnea predominantly of non-cardiac cause (e.g. COPD).
• Atrial fibrillation with a heart rate greater than 90 beats per minute at rest.
• Musculoskeletal or neurological disease that precludes the patient from performing exercise.

Age

• Active neoplasm with life expectancy \<2 years.

Other

• Inclusion in another interventional study.
• Explicit contraindications to performing exercise.
• Comorbidities that preclude the patient from engaging in a CR program.

• Adult patients with HF of New York Heart Association functional class II or III.
• Meets HF diagnostic criteria of Guidelines
• On optimal tolerated medical therapy.
• Deemed by the treating physician as stable for at least 1 month.
• Able to attend the health center three times a week for the first month, and twice a week for the 2nd and 3rd months
• Owns a mobile phone
• Patient consents to participate in the study by signing an informed consent form.